Flozins, inhibitors of type 2 renal sodium-glucose co-transporter – not only antihyperglycemic drugs
The kidneys play a crucial role in the regulation of the carbohydrate metabolism. In normal physiological conditions, the glucose that filters through the renal glomeruli is subsequently nearly totally reabsorbed in the proximal renal tubules. Two transporters are engaged in this process: sodium-glu...
Main Authors: | Mizerski Grzegorz, Kicinski Pawel, Jaroszynski Andrzej |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2015-09-01
|
Series: | Current Issues in Pharmacy and Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/cipms-2015-0063 |
Similar Items
-
The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress—Role of New Drugs, Flozins
by: Patryk Bodnar, et al.
Published: (2023-08-01) -
Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action
by: Anna Kochanowska, et al.
Published: (2023-06-01) -
SGLT2 inhibitors - a breakthrough in treatment of heart failure and their multipotential beneficial role in cardiology, diabetology, nephrology and neurology
by: Marta Bogowska, et al.
Published: (2023-10-01) -
Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors and CKD: Are You a #Flozinator?
by: Anoushka Krishnan, et al.
Published: (2023-04-01) -
Psoriasiform lesions as a side effect of SGLT-2 therapy
by: Jakub Krzysztof Gałązka, et al.
Published: (2023-01-01)